![【重磅录像】颜宁:“AI在结构生物学中的未达之地”](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
赛诺菲有意收购Mirati Therapeutics。后者是安进在KRAS赛道的强有力的竞争对手。
![快讯!赛诺菲有意收购安进的竞争对手Mirati Therapeutics?Mirati股价大涨45%!~](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![快讯!赛诺菲有意收购安进的竞争对手Mirati Therapeutics?Mirati股价大涨45%!~](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
(图片来源:MSN)
该潜在收购是否成真呢?
药时代将继续跟踪报道。欢迎广大朋友们关注!
参考资料:
-
Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase: Bloomberg
-
Sanofi to Explore Acquisition of Cancer Drugmaker Mirati Bloomberg News
-
Mirati Therapeutics soars on report of Sanofi takeover interest
-
其它公开资料
![快讯!赛诺菲有意收购安进的竞争对手Mirati Therapeutics?Mirati股价大涨45%!~](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![快讯!赛诺菲有意收购安进的竞争对手Mirati Therapeutics?Mirati股价大涨45%!~](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
![快讯!赛诺菲有意收购安进的竞争对手Mirati Therapeutics?Mirati股价大涨45%!~](https://www.drugtimes.cn/wp-content/themes/justnews/themer/assets/images/lazy.png)
本篇文章来源于微信公众号: 药时代
发布者:haitao.zhao,转载请首先联系contact@drugtimes.cn获得授权